Please read the announcement in the attachment
Attachment
- 2023_Tax-exempt_merger_ruling
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 46,770 | 46,930 | 14:15 | |
| 46,790 | 46,910 | 14:15 |
Novozymes A/S: Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger
© 2023 GlobeNewswire (Europe)
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:18 | Chr. Hansen Holding A/S: Combination between Novozymes and Chr. Hansen approved by Novozymes' shareholders | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. MARCH 30, 2023... ► Artikel lesen | |
| 13:12 | Novozymes A/S: Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders | ||
| Di | Chr. Hansen Holding A/S: Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion | ||
| Di | Novozymes A/S: Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion | Please read the full announcement in PDF
► Artikel lesen | |
| 08.03. | Chr. Hansen Holding A/S: Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:24 | Resolutions from Novozymes A/S' Extraordinary Shareholders' Meeting on 30 March 2023 | ||
| 13:18 | Chr. Hansen Holding A/S: Combination between Novozymes and Chr. Hansen approved by Novozymes' shareholders | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. MARCH 30, 2023... ► Artikel lesen | |
| 13:12 | Novozymes A/S: Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders | ||
| Di | Chr. Hansen Holding A/S: Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion | ||
| Di | Novozymes A/S: Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion | Please read the full announcement in PDF
► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
